Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

The objectives of this study were to evaluate long-term safety and efficacy of caplacizumab, to evaluate safety and efficacy of repeated use of caplacizumab and to characterize long-term impact of acq...

Lead sponsor: Sanofi•8 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 3

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

NCT02553317 · Acquired Thrombotic Thrombocytopenic Purpura

UNKNOWNPhase 2

A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)

NCT04021173 · Acquired Thrombotic Thrombocytopenic Purpura

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 28, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment104

Start dateOct 2016

Last updatedMar 28, 2022

Condition

Acquired Thrombotic Thrombocytopenic Purpura

Locations shown

Investigator site

St Louis, Missouri

Investigator site

Valhalla, New York

Investigator Site

Durham, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 28, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions